Economic Burden of Adverse Events in Patients With Metastatic Renal Cell Carcinoma
Authors:
- 2 December 2013
- journal article
- Published by Elsevier in Clinical Therapeutics
- Vol. 35 (12) , 1955-1963.e2
Abstract
No abstract availableKeywords
This publication has 3 references indexed in Scilit:
- Safety and treatment patterns of angiogenesis inhibitors in patients with metastatic renal cell carcinoma: evidence from US community oncology clinicsMedical Oncology, 2011
- Recent advances in the treatment of renal cell carcinoma and the role of targeted therapiesEuropean Journal of Cancer, 2008
- SYSTEMIC THERAPY FOR RENAL CELL CARCINOMAJournal of Urology, 2000